PT1094791E - Formulacoes tixotropicas para o enchimento de capsulas duras - Google Patents

Formulacoes tixotropicas para o enchimento de capsulas duras

Info

Publication number
PT1094791E
PT1094791E PT99929399T PT99929399T PT1094791E PT 1094791 E PT1094791 E PT 1094791E PT 99929399 T PT99929399 T PT 99929399T PT 99929399 T PT99929399 T PT 99929399T PT 1094791 E PT1094791 E PT 1094791E
Authority
PT
Portugal
Prior art keywords
filling
compositions
tixotropic
formulations
consistency
Prior art date
Application number
PT99929399T
Other languages
English (en)
Inventor
Eric Goutay
Joel Bougaret
Elie Leverd
Pascal Lombardin
Jean-Louis Grossiord
Monique Seiller
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of PT1094791E publication Critical patent/PT1094791E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT99929399T 1998-07-07 1999-07-05 Formulacoes tixotropicas para o enchimento de capsulas duras PT1094791E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9808664A FR2781373B1 (fr) 1998-07-07 1998-07-07 Formulations thixotropes pour le remplissage de gelules

Publications (1)

Publication Number Publication Date
PT1094791E true PT1094791E (pt) 2003-08-29

Family

ID=9528339

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99929399T PT1094791E (pt) 1998-07-07 1999-07-05 Formulacoes tixotropicas para o enchimento de capsulas duras

Country Status (15)

Country Link
US (1) US6709675B1 (pt)
EP (1) EP1094791B1 (pt)
JP (1) JP2002519370A (pt)
CN (1) CN1211124C (pt)
AT (1) ATE237318T1 (pt)
AU (1) AU760665B2 (pt)
BR (1) BR9911905A (pt)
CA (1) CA2337273A1 (pt)
DE (1) DE69906974T2 (pt)
DK (1) DK1094791T3 (pt)
ES (1) ES2197647T3 (pt)
FR (1) FR2781373B1 (pt)
PT (1) PT1094791E (pt)
WO (1) WO2000001371A1 (pt)
ZA (1) ZA200100052B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100598871B1 (ko) * 2001-09-10 2006-07-12 에프. 호프만-라 로슈 아게 유성 요변성 제제
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US7109247B2 (en) 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US20060153909A1 (en) * 2003-06-27 2006-07-13 Soko Motoune Hard capsule
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
US8318210B2 (en) * 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
WO2006132307A1 (ja) 2005-06-10 2006-12-14 Pierre Fabre Medicament S.A. 安定化されたミルナシプラン製剤
CN100335135C (zh) * 2005-11-04 2007-09-05 天津太平洋制药有限公司 银杏叶提取物胶囊组合物及其制备方法
US20080319083A1 (en) * 2006-01-27 2008-12-25 Asahi Kasei Pharma Corporation Medicine for transnasal administration
WO2008088601A2 (en) * 2007-01-16 2008-07-24 Texas Tech University System Method and apparatus for gender selection based on ph
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
CN103037851A (zh) * 2010-06-02 2013-04-10 安斯泰来德国有限公司 苯达莫司汀的口服剂型
US8978783B2 (en) 2011-05-26 2015-03-17 Smith International, Inc. Jet arrangement on an expandable downhole tool
US20160331695A1 (en) * 2014-01-31 2016-11-17 Fuji Capsule Co., Ltd. Capsule Formulation
DE102016109669A1 (de) 2016-05-25 2017-11-30 Tiernahrung Deuerer Gmbh Verfahren zum Herstellen eines Tiernahrungsproduktes
CA3076820A1 (en) 2017-10-19 2019-04-25 Signpath Pharma, Inc. Protective effect of dmpc, dmpg, dmpc/dmpg, lysopg and lysopc against drugs that cause channelopathies

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202888A (en) 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
USH672H (en) * 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
DK0461290T3 (da) * 1990-06-14 1994-02-21 Henning Berlin Gmbh Væskefyldte stikkapsler
EP0517412A1 (en) * 1991-06-03 1992-12-09 MERCK SHARP & DOHME LTD. Pharmaceutical formulations of a benzodiazepine
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
ES2168481T3 (es) * 1995-06-09 2002-06-16 Scherer Technologies Inc R P Capsulas de gelatina blanda conteniendo un material en particulas.
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
TW426516B (en) * 1996-12-06 2001-03-21 Fujisawa Pharmaceutical Co An oral pharmaceutical composition in solid dispersion containing water-insoluble tricyclic compounds
FR2761265B1 (fr) * 1997-03-28 1999-07-02 Sanofi Sa Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6365181B1 (en) * 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition

Also Published As

Publication number Publication date
CA2337273A1 (fr) 2000-01-13
BR9911905A (pt) 2001-03-27
ES2197647T3 (es) 2004-01-01
FR2781373B1 (fr) 2001-09-21
DK1094791T3 (da) 2003-08-11
EP1094791A1 (fr) 2001-05-02
FR2781373A1 (fr) 2000-01-28
DE69906974D1 (de) 2003-05-22
CN1211124C (zh) 2005-07-20
DE69906974T2 (de) 2004-02-26
JP2002519370A (ja) 2002-07-02
ZA200100052B (en) 2001-07-16
US6709675B1 (en) 2004-03-23
ATE237318T1 (de) 2003-05-15
WO2000001371A1 (fr) 2000-01-13
EP1094791B1 (fr) 2003-04-16
CN1308522A (zh) 2001-08-15
AU4622799A (en) 2000-01-24
AU760665B2 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
PT1094791E (pt) Formulacoes tixotropicas para o enchimento de capsulas duras
GT200800037A (es) Solucion de cloruro de sodio para reconstitucion o dilucion de farmacos
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
ECSP067062A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
ES2173708T3 (es) Composicion filmogena que comprende un poliuretano en dispersion acuosa y un agente plastificante.
RS50025B (sr) Farmaceutski preparati koji mogu da budu gelirani
BRPI0707612B8 (pt) vaso lacrado e formulações líquidas contidas no mesmo
EE200300109A (et) Protsess vedela emulsioonkompositsiooni valmistamiseks ja emulsiooni kontsentraadi valmistamiseks, farmatseutiline kompositsioon, emulsiooni kontsentraat, komplekt ja emulsioonkompositsioon
AU1301199A (en) Drug delivery systems utilizing liquid crystal structures
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
EA200601588A1 (ru) Стабилизированные перенасыщенные твёрдые растворы липофильных лекарственных средств
EA200702320A1 (ru) Соединения trpv1 агониста и способы их получения и применения
TW200505500A (en) Non-aqueous single phase vehicles and formulations utilizing such vehicles
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
EP2269631A3 (en) Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics
WO2001015734A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
PL1952142T3 (pl) Kompozycja do rozpuszczania do badania rozpuszczalności leku
MX253134B (es) Colorante para alimentos y farmaceuticos.
SV2003001098A (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
EP3354283A3 (en) Pharmaceutical capsule composition comprising silodosin
BRPI0619339B8 (pt) composições filmogênicas sólidas prontas destinadas à realização de soluções ou dispersões de revestimento para formas sólidas ou semi-sólidas
Szűts et al. Study of the effects of drugs on the structures of sucrose esters and the effects of solid-state interactions on drug release
JP6971871B2 (ja) カプセル及びその製造方法、並びにカプセル入り化粧料及びその製造方法
DE60120630D1 (de) Pharmazeutische Zusammensetzung enthaltend Xanthangummi
WO2020053658A3 (en) Non-aqueous chemotherapeutic solutions for oral dosage